Clinical Trials Directory

Trials / Completed

CompletedNCT02364167

Acupuncture for Pain Control After Elective Caesarean Section

Acupuncture vs. Placebo Acupuncture and vs. Standard Therapy for Pain Control After Elective Caesarean Section - a Randomized Controlled Trial

Status
Completed
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
180 (actual)
Sponsor
University Medicine Greifswald · Academic / Other
Sex
Female
Age
19 Years – 45 Years
Healthy volunteers
Not accepted

Summary

The study entitled "Acupuncture vs. placebo acupuncture and vs. standard therapy for pain control after elective caesarian section - a randomized controlled trial" aims to investigate whether acupuncture with indwelling fixed needles reduces pain and analgesic requirement as compared to placebo and standard therapy in patients after after elective caesarian section (CS) in the period from January 2015 to May 2016. For that purpose 180 adult patients scheduled to elective elective CS in spinal anesthesia will be recruited according to eligibility criteria. 120 patients will be randomized either to verum or placebo acupuncture, 60 patients will be included in non-randomized "standard therapy" arm. The outcome measures are: postoperative analgesic requirement, pain intensity, incidence of side effects and physiological parameters.

Conditions

Interventions

TypeNameDescription
DRUGStandard therapyStandard therapy includes pharmacologic treatment of postoperative pain according to the standards of our University hospital
DEVICEVerum acupunctureVerum acupuncture will be performed using indwelling permanent acupuncture needles "New Pyonex" with 1,5 mm length, manufactured by Seirin Corp. Japan
OTHERPlacebo acupuncturePlacebo acupuncture will be performed using the placebo "New Pyonex" adhesive tapes, mimicking the needles, manufactured by Seirin Corp. Japan

Timeline

Start date
2015-01-13
Primary completion
2018-06-27
Completion
2018-06-27
First posted
2015-02-16
Last updated
2021-01-11

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT02364167. Inclusion in this directory is not an endorsement.